Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments
NonrulemakingNoticeFDA-2026-N-3499-0001
Comments
2
Awaiting comments
Deadline
8 days
Closes Jul 1, 2026
Net supportiSupport minus oppose · campaigns included
+100%
+100% excluding campaigns
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- May 1, 2026
- Comment period
- May 1, 2026 – Jul 1, 2026
- Agency
- Food and Drug Administration (FDA)
- FR Doc
- 2026-08521
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Analyzed 1 of 2 comments
50%· analysis in progress
Stance breakdown
+100%
Net support
Support1Not yet analyzed1
Aggregates include form-letter campaigns. Excluding them, net support is +100% across organic comments.
Who commented
Breakdown by commenter type.
Individual
1
Not yet analyzed
1
Comments over time
Weekly arrivals, stacked by stance.
Posted May 1, 2026Deadline Jul 1, 2026
Apr 27May 4
Support1Oppose0Other0
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
100%
0%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.